»
New Psychoactive Substances in Europe Course
The training is for service providers and peers supporting NPS users in Europe.
From essential medicine to illicit commodity: new EU report reveals how ketamine diversion is fuelling the illicit market in Europe
Ketamine produced legitimately outside the EU to make medicines is increasingly finding its way onto Europe’s illicit drug...